Investment Agreements in the Pharmaceuticals Industry

76 Contracts & Agreements

Browse by Company

ALIMERA SCIENCES INC (1 contract)
AmeriCann, Inc. (4)
Amphastar Pharma (2)
ANI Pharma Inc (1)
BiondVax Pharmaceuticals Ltd. (1)
BODY & MIND INC. (2)
Bright Green Corp (1)
CANNAPHARMARX, INC. (1)
Canopy Growth Corp (1)
Cantabio Pharmaceuticals Inc. (1)
CARDAX, INC. (1)
Charlotte's Web Holdings, Inc. (1)
China Pharmaceuticals Inc (1)
CLS Holdings USA, Inc. (1)
Eleison Pharmaceuticals Inc (1)
FRONTIER OILFIELD SERVICES INC (1)
Hoth Therapeutics, Inc. (1)
JUNIPER PHARMACEUTICALS INC (1)
Lexaria Bioscience Corp. (1)
Molecular Insight Pharmaceuticals, Inc. (2)
MYnd Analytics, Inc. (1)
Notis Global, Inc. (2)
OPIANT PHARMACEUTICALS, INC. (12)
Panacea Acquisition Corp (3)
Pfizer (1)
Phibro Animal Health Corporation (1)
PLAYERS NETWORK (2)
ProPhase Labs, Inc. (2)
PROTECT PHARMACEUTICAL Corp (1)
RADIENT PHARMACEUTICALS Corp (1)
Recro Pharma, Inc. (1)
Sagent Pharmaceuticals, Inc. (1)
SIGA TECHNOLOGIES INC (2)
TAURIGA SCIENCES, INC. (3)
Terra Tech Corp. (1)
The Medicines Company (1)
TherapeuticsMD, Inc. (1)
Tilray, Inc. (4)
United Cannabis Corp (5)
Valera Pharmaceuticals Inc (2)
VIA Pharmaceuticals, Inc. (2)
WEED, INC. (1)

Recent Contracts

Redemption Agreement dated February 22, 2024, by and among the Company, Tribeca Investment Partners PTY LTD Tribeca Global Natural Resources Fund and the other parties named... (CLS Holdings USA, Inc., Filed With SEC on February 26, 2024)
Pricing Agreement, dated May 16, 2023, among Pfizer Investment Enterprises Pte. Ltd., Pfizer Inc. and the several underwriters listed on Schedule I to the Pricing Agreement (Pfizer, Filed With SEC on May 19, 2023)
Fifth Amendment Exit Fee Agreement dated as of March 24, 2023, by and among Alimera Sciences, Inc., SLR Investment Corp, as Collateral Agent, and the parties signatory thereto as... (ALIMERA SCIENCES INC, Filed With SEC on May 15, 2023)
Amendment Agreement dated August 9, 2022, to Finance Contract dated June 19, 2017 and as amended from time to time, by and between BiondVax Pharmaceuticals Ltd. and the European... (BiondVax Pharmaceuticals Ltd., Filed With SEC on April 17, 2023)
Subscription Agreement, dated November 14, 2022, by and between BT DE Investments, Inc. a wholly-owned subsidiary of BAT Group and Charlottes Web Holdings, Inc (Charlotte's Web Holdings, Inc., Filed With SEC on November 23, 2022)
Subscription and Investment Representation Agreement dated November 2, 2022 (Hoth Therapeutics, Inc., Filed With SEC on November 3, 2022)
Consent Agreement dated October 24, 2022 by and between CBG Holdings LLC, Greenstar Canada Investment Limited Partnership and Canopy Growth Corporation (Canopy Growth Corp, Filed With SEC on October 26, 2022)
Placement Agent Agreement dated September 12, 2022 by and between the Company and EF Hutton, division of Benchmark Investments, LLC (Bright Green Corp, Filed With SEC on September 13, 2022)
Capacity Investment Agreement between Aptar Group Inc. and Opiant Pharmaceuticals, Inc. dated June 8, 2022 (OPIANT PHARMACEUTICALS, INC., Filed With SEC on August 11, 2022)
Amended and Restated Assignment and Assumption Agreement, dated as of June 14, 2022, by and among the Company, HT Investments MA LLC and HEXO (Tilray, Inc., Filed With SEC on June 14, 2022)
Amending Agreement to Transaction Agreement, dated as of June 14, 2022, by and among the Company, HT Investments MA LLC and HEXO (Tilray, Inc., Filed With SEC on June 14, 2022)
Assignment and Assumption Agreement, dated as of April 11, 2022, by and among the Company, HT Investments MA LLC and HEXO Corp (Tilray, Inc., Filed With SEC on April 12, 2022)
Transaction Agreement, dated as of April 11, 2022, by and among the Company, HT Investments MA LLC and HEXO Corp (Tilray, Inc., Filed With SEC on April 12, 2022)
Engagement Agreement, dated as of August 22, 2021, between Eleison Pharmaceuticals Inc. and Gordian Investments, LLC (Eleison Pharmaceuticals Inc, Filed With SEC on January 24, 2022)
Investment agreement with SciSparc Ltd. dated March 1, 2021 (TAURIGA SCIENCES, INC., Filed With SEC on June 29, 2021)
Equity Commitment and Investment Agreement dated March 8, 2021 by and between ANI Pharmaceuticals, Inc. and Ampersand 2020 Limited Partnership (ANI Pharma Inc, Filed With SEC on March 9, 2021)
Investment Banking Agreement (WEED, INC., Filed With SEC on March 8, 2021)
Amendment to Investment Agreement, dated November 18, 2020 (TAURIGA SCIENCES, INC., Filed With SEC on November 19, 2020)
Letter Agreement, dated June 30, 2020, among the Company, the Sponsor, Cowen Investments and the Companys officers and directors (Panacea Acquisition Corp, Filed With SEC on July 6, 2020)
Form of Letter Agreement among the Registrant and the Registrants officers and directors, EcoR1 Panacea Holdings, LLC and Cowen Investments II LLC (Panacea Acquisition Corp, Filed With SEC on June 23, 2020)
Securities Subscription Agreement, dated May 7, 2020, between the Registrant and Cowen Investments II LLC (Panacea Acquisition Corp, Filed With SEC on June 12, 2020)
Investment Agreement between Tangiers Global, LLC and the Company, dated January 21, 2020 (TAURIGA SCIENCES, INC., Filed With SEC on January 29, 2020)
Investment and Royalty Agreement, dated March 12, 2018 by and between Aron Funds, LLC and EWSD I LLC (Notis Global, Inc., Filed With SEC on November 27, 2019)
Agreement, dated March 25, 2019, by and among Recro Pharma, Inc., Engine Capital, L.P., Engine Jet Capital, L.P., Engine Investments, LLC, and Arnaud Ajdler (Recro Pharma, Inc., Filed With SEC on March 28, 2019)
Investment Agreement between Australis Capital Inc. and Body and Mind Inc., dated January 31, 2019 (BODY & MIND INC., Filed With SEC on February 6, 2019)
Investment Agreement, dated January 15, 2019, by and among Lexaria Bioscience Corp., Lexaria Nicotine LLC, PoViva Corp. and Altria Ventures Inc (Lexaria Bioscience Corp., Filed With SEC on January 22, 2019)
Agreement, by and between the Company and RSJ Investments SICAV a.s. acting in respect of its sub-fund (podfond) RSJ Gradus podfond, RSJ Investment SICAV a.s., effective as of... (MYnd Analytics, Inc., Filed With SEC on December 11, 2018)
Investment Agreement between Australis Capital Inc. and Body and Mind Inc., dated October 30, 2018 (BODY & MIND INC., Filed With SEC on November 5, 2018)
August 31, 2018 Investment Agreement with Tangiers Global, LLC (United Cannabis Corp, Filed With SEC on September 10, 2018)
Subscription Agreement between Amphastar Cayman, LLC and KYW Investment partnership dated June 28, 2018 (Amphastar Pharma, Filed With SEC on August 9, 2018)
2018 Investment Agreement with Tangiers Global, LLC (United Cannabis Corp, Filed With SEC on February 20, 2018)
Investment Agreement with Mountain States Capital, LLC (AmeriCann, Inc., Filed With SEC on February 14, 2018)
Investment Agreement with Mountain States Capital, LLC (AmeriCann, Inc., Filed With SEC on February 2, 2018)
Investment Agreement with Mountain States Capital, LLC (AmeriCann, Inc., Filed With SEC on December 21, 2017)
Investment Agreement with Mountain States Capital, LLC (AmeriCann, Inc., Filed With SEC on September 7, 2017)
AMENDMENT TO INVESTMENT AGREEMENT (OPIANT PHARMACEUTICALS, INC., Filed With SEC on June 2, 2017)
AMENDMENT TO INVESTMENT AGREEMENT (OPIANT PHARMACEUTICALS, INC., Filed With SEC on April 18, 2017)
Investment Agreements with Tangiers Global, LLC (United Cannabis Corp, Filed With SEC on March 23, 2017)
Investment Agreements with Tangiers Global, LLC (United Cannabis Corp, Filed With SEC on March 7, 2017)
Investment Agreements with Tangiers Global, LLC (United Cannabis Corp, Filed With SEC on February 24, 2017)